Author:
Alfaro Arenas Ramona, ,Rosell Andreo Jordi,Heine Suñer Damián
Funder
Abbott Laboratories
Instituto de Salud Carlos III
Reference21 articles.
1. Abrams, L., Cronister, A., Brown, W. T., Tassone, F., Sherman, S. L., Finucane, B., et al. (2012). Newborn, carrier, and early childhood screening recommendations for fragile X. Pediatrics, 130(6), 1126–1135. doi:
10.1542/peds.2012-0693
.
2. Alfaro Arenas, R., Rosell Andreo, J., Heine Suñer, D., & Group for the study of FXS in the Balearic Islands. (2016). Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands. American Journal of Medical Genetics. Part B, 9999, 1–9.
3. Basehore, M. J., Marlowe, N. M., Jones, J. R., Behlendorf, D. E., Laver, T. A., & Friez, M. J. (2012). Validation of a screening tool for the rapid and reliable detection of CGG trinucleotide repeat expansions in FMR1. Genetic Testing and Molecular Biomarkers, 16(6), 465–470. doi:
10.1089/gtmb.2011.0134
.
4. Berkenstadt, M., Ries-Levavi, L., Cuckle, H., Peleg, L., & Barkai, G. (2007). Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests. Prenatal Diagnosis, 27(11), 991–994. doi:
10.1002/pd.1815
.
5. Berry-Kravis, E. (2014). Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome. Pediatric Neurology, 50(4), 297–302. doi:
10.1016/j.pediatrneurol.2013.12.001
.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献